Drugging sphingosine kinases

ACS Chemical Biology

Volumn 10, Issue 1, 2015, Pages 225-233

  Santos, Webster L ^a   Lynch, Kevin R ^b  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE DERIVATIVE; SPHINGOSINE KINASE; ADENOSINE TRIPHOSPHATE; CERAMIDE; ENZYME INHIBITOR; LYSOPHOSPHOLIPID; PHOSPHOTRANSFERASE; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

CANCER CELL LINE; CANCER INHIBITION; CELL METABOLISM; CRYSTAL STRUCTURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; HUMAN; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOCATALYSIS; CHEMISTRY; DRUG DEVELOPMENT; METABOLISM; PROCEDURES; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BIOCATALYSIS; CERAMIDES; DRUG DISCOVERY; ENZYME INHIBITORS; HUMANS; LYSOPHOSPHOLIPIDS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 84921380792     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb5008426     Document Type: Review

References (71)

1. Kunkel, G. T., Maceyka, M., Milstien, S., and Spiegel, S. (2013) Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond Nat. Rev. Drug Discovery 12, 688-702
2. Bigaud, M., Guerini, D., Billich, A., Bassilana, F., and Brinkmann, V. (2014) Second generation S1P pathway modulators: research strategies and clinical developments Biochim. Biophys. Acta 1841, 745-758
3. Brinkmann, V. (2007) Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology Pharmacol. Ther. 115, 84-105
4. Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., Foster, C. A., Zollinger, M., and Lynch, K. R. (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors J. Biol. Chem. 277, 21453-21457
5. Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G. J., Card, D., Keohane, C., Rosenbach, M., Hale, J., Lynch, C. L., Rupprecht, K., Parsons, W., and Rosen, H. (2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists Science 296, 346-349
6. Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S., and Burtin, P. (2010) Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis Nat. Rev. Drug Discovery 9, 883-897
7. Liu, H., Sugiura, M., Nava, V. E., Edsall, L. C., Kono, K., Poulton, S., Milstien, S., Kohama, T., and Spiegel, S. (2000) Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform J. Biol. Chem. 275, 19513-19520
8. Zemann, B., Urtz, N., Reuschel, R., Mechtcheriakova, D., Bornancin, F., Badegruber, R., Baumruker, T., and Billich, A. (2007) Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice Immunol. Lett. 109, 56-63
9. Allende, M. L., Sasaki, T., Kawai, H., Olivera, A., Mi, Y. D., van Echten-Deckert, G., Hajdu, R., Rosenbach, M., Keohane, C. A., Mandala, S., Spiegel, S., and Proia, R. L. (2004) Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720 J. Biol. Chem. 279, 52487-52492
10. Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S., and Proia, R. L. (2005) Essential role for sphingosine kinases in neural and vascular development Mol. Cell. Biol. 25, 11113-11121
11. Plano, D., Amin, S., and Sharma, A. K. (2014) Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors J. Med. Chem. 57, 5509-5524
12. Wang, Z., Min, X., Xiao, S. H., Johnstone, S., Romanow, W., Meininger, D., Xu, H., Liu, J., Dai, J., An, S., Thibault, S., and Walker, N. (2013) Molecular basis of sphingosine kinase 1 substrate recognition and catalysis Structure 21, 798-809
13. Nagahashi, M., Kim, E. Y., Yamada, A., Ramachandran, S., Allegood, J. C., Hait, N. C., Maceyka, M., Milstien, S., Takabe, K., and Spiegel, S. (2013) Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network FASEB J. 27, 1001-1011
14. Laviad, E. L., Albee, L., Pankova-Kholmyansky, I., Epstein, S., Park, H., Merrill, A. H., Jr., and Futerman, A. H. (2008) Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate J. Biol. Chem. 283, 5677-5684
15. Hait, N. C., Allegood, J., Maceyka, M., Strub, G. M., Harikumar, K. B., Singh, S. K., Luo, C., Marmorstein, R., Kordula, T., Milstien, S., and Spiegel, S. (2009) Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate Science 325, 1254-1257
16. Alvarez, S. E., Harikumar, K. B., Hait, N. C., Allegood, J., Strub, G. M., Kim, E. Y., Maceyka, M., Jiang, H., Luo, C., Kordula, T., Milstien, S., and Spiegel, S. (2010) Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2 Nature 465, 1084-1088
17. Strub, G. M., Paillard, M., Liang, J., Gomez, L., Allegood, J. C., Hait, N. C., Maceyka, M., Price, M. M., Chen, Q., Simpson, D. C., Kordula, T., Milstien, S., Lesnefsky, E. J., and Spiegel, S. (2011) Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration FASEB J. 25, 600-612
18. Chipuk, J. E., McStay, G. P., Bharti, A., Kuwana, T., Clarke, C. J., Siskind, L. J., Obeid, L. M., and Green, D. R. (2012) Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis Cell 148, 988-1000
19. Sato, K., Malchinkhuu, E., Horiuchi, Y., Mogi, C., Tomura, H., Tosaka, M., Yoshimoto, Y., Kuwabara, A., and Okajima, F. (2007) Critical role of ABCA1 transporter in sphingosine 1-phosphate release from astrocytes J. Neurochem. 103, 2610-2619
20. Takabe, K., Kim, R. H., Allegood, J. C., Mitra, P., Ramachandran, S., Nagahashi, M., Harikumar, K. B., Hait, N. C., Milstien, S., and Spiegel, S. (2010) Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2 J. Biol. Chem. 285, 10477-10486
21. Mendoza, A., Breart, B., Ramos-Perez, W. D., Pitt, L. A., Gobert, M., Sunkara, M., Lafaille, J. J., Morris, A. J., and Schwab, S. R. (2012) The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate Cell Rep. 2, 1104-1110
22. Yatomi, Y., Igarashi, Y., Yang, L., Hisano, N., Qi, R., Asazuma, N., Satoh, K., Ozaki, Y., and Kume, S. (1997) Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum J. Biochem. 121, 969-973
23. Sensken, S. C., Bode, C., Nagarajan, M., Peest, U., Pabst, O., and Graler, M. H. (2010) Redistribution of sphingosine 1-phosphate by sphingosine kinase 2 contributes to lymphopenia J. Immunol. 184, 4133-4142
24. Venkataraman, K., Lee, Y.-M., Michaud, J., Thangada, S., Ai, Y., Bonkovsky, H. L., Parikh, N. S., Habrukowich, C., and Hla, T. (2008) Vascular endothelium as a contributor of plasma sphingosine 1-phosphate Circ. Res. 102, 669-676
25. Peest, U., Sensken, S. C., Andreani, P., Hanel, P., Van Veldhoven, P. P., and Graler, M. H. (2008) S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake J. Cell. Biochem. 104, 756-772
26. Salous, A. K., Panchatcharam, M., Sunkara, M., Mueller, P., Dong, A., Wang, Y., Graf, G. A., Smyth, S. S., and Morris, A. J. (2013) Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice J. Lipid Res. 54, 2775-2784
27. Kharel, Y., Mathews, T. P., Gellett, A. M., Tomsig, J. L., Kennedy, P. C., Moyer, M. L., Macdonald, T. L., and Lynch, K. R. (2011) Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate Biochem. J. 440, 345-353
28. Zemann, B., Kinzel, B., Muller, M., Reuschel, R., Mechtcheriakova, D., Urtz, N., Bornancin, F., Baumruker, T., and Billich, A. (2006) Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720 Blood 107, 1454-1458
29. Olivera, A., Mizugishi, K., Tikhonova, A., Ciaccia, L., Odom, S., Proia, R. L., and Rivera, J. (2007) The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis Immunity 26, 287-297
30. Marsolais, D. and Rosen, H. (2009) Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules Nat. Rev. Drug Discovery 8, 297-307
31. Wang, L. and Dudek, S. M. (2009) Regulation of vascular permeability by sphingosine 1-phosphate Microvasc. Res. 77, 39-45
32. Ruckhaberle, E., Rody, A., Engels, K., Gaetje, R., von Minckwitz, G., Schiffmann, S., Grosch, S., Geisslinger, G., Holtrich, U., Karn, T., and Kaufmann, M. (2008) Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer Breast Cancer Res. Treat. 112, 41-52
33. Kawamori, T., Kaneshiro, T., Okumura, M., Maalouf, S., Uflacker, A., Bielawski, J., Hannun, Y. A., and Obeid, L. M. (2009) Role for sphingosine kinase 1 in colon carcinogenesis FASEB J. 23, 405-414
34. Pyne, S., Edwards, J., Ohotski, J., and Pyne, N. J. (2012) Sphingosine 1-phosphate receptors and sphingosine kinase 1: novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers Front. Oncol. 2, 168
35. Li, J., Guan, H. Y., Gong, L. Y., Song, L. B., Zhang, N., Wu, J., Yuan, J., Zheng, Y. J., Huang, Z. S., and Li, M. (2008) Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival Clin. Cancer Res. 14, 6996-7003
36. Zhang, Y., Berka, V., Song, A., Sun, K., Wang, W., Zhang, W., Ning, C., Li, C., Zhang, Q., Bogdanov, M., Alexander, D. C., Milburn, M. V., Ahmed, M. H., Lin, H., Idowu, M., Zhang, J., Kato, G. J., Abdulmalik, O. Y., Zhang, W., Dowhan, W., Kellems, R. E., Zhang, P., Jin, J., Safo, M., Tsai, A. L., Juneja, H. S., and Xia, Y. (2014) Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression J. Clin. Invest. 124, 2750-2761
37. Buehrer, B. M. and Bell, R. M. (1992) Inhibition of sphingosine kinase in vitro and in platelets. Implications for signal transduction pathways J. Biol. Chem. 267, 3154-3159
38. Coward, J., Ambrosini, G., Musi, E., Truman, J. P., Haimovitz-Friedman, A., Allegood, J. C., Wang, E., Merrill, A. H., Jr., and Schwartz, G. K. (2009) Safingol (l -threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway Autophagy 5, 184-193
39. Melendez, A. J., Carlos-Dias, E., Gosink, M., Allen, J. M., and Takacs, L. (2000) Human sphingosine kinase: molecular cloning, functional characterization and tissue distribution Gene 251, 19-26
40. Paugh, S. W., Paugh, B. S., Rahmani, M., Kapitonov, D., Almenara, J. A., Kordula, T., Milstien, S., Adams, J. K., Zipkin, R. E., Grant, S., and Spiegel, S. (2008) A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia Blood 112, 1382-1391
41. Kapitonov, D., Allegood, J. C., Mitchell, C., Hait, N. C., Almenara, J. A., Adams, J. K., Zipkin, R. E., Dent, P., Kordula, T., Milstien, S., and Spiegel, S. (2009) Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts Cancer Res. 69, 6915-6923
42. French, K. J., Schrecengost, R. S., Lee, B. D., Zhuang, Y., Smith, S. N., Eberly, J. L., Yun, J. K., and Smith, C. D. (2003) Discovery and evaluation of inhibitors of human sphingosine kinase Cancer Res. 63, 5962-5969
43. French, K. J., Upson, J. J., Keller, S. N., Zhuang, Y., Yun, J. K., and Smith, C. D. (2006) Antitumor activity of sphingosine kinase inhibitors J. Pharmacol. Exp. Ther. 318, 596-603
44. Lim, K. G., Tonelli, F., Li, Z., Lu, X., Bittman, R., Pyne, S., and Pyne, N. J. (2011) FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells J. Biol. Chem. 286, 18633-18640
45. Maines, L. W., Fitzpatrick, L. R., French, K. J., Zhuang, Y., Xia, Z. P., Keller, S. N., Upson, J. J., and Smith, C. D. (2008) Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase Dig. Dis. Sci. 53, 997-1012
46. Loveridge, C., Tonelli, F., Leclercq, T., Lim, K. G., Long, J. S., Berdyshev, E., Tate, R. J., Natarajan, V., Pitson, S. M., Pyne, N. J., and Pyne, S. (2010) The sphingosine kinase 1 inhibitor 2-(p -hydroxyanilino)-4-(p -chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells J. Biol. Chem. 285, 38841-38852
47. Ren, S., Xin, C., Pfeilschifter, J., and Huwiler, A. (2010) A novel mode of action of the putative sphingosine kinase inhibitor 2-(p -hydroxyanilino)-4-(p -chlorophenyl) thiazole (SKI II): induction of lysosomal sphingosine kinase 1 degradation Cell. Physiol. Biochem. 26, 97-104
48. Cingolani, F., Casasampere, M., Sanllehi, P., Casas, J., Bujons, J., and Fabrias, G. (2014) Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II J. Lipid Res. 55, 1711-1720
49. Snider, A. J., Ruiz, P., Obeid, L. M., and Oates, J. C. (2013) Inhibition of sphingosine kinase-2 in a murine model of lupus nephritis PLoS One 8, e53521
50. Fitzpatrick, L. R., Green, C., Maines, L. W., and Smith, C. D. (2011) Experimental osteoarthritis in rats is attenuated by ABC294640, a selective inhibitor of sphingosine kinase-2 Pharmacology 87, 135-143
51. Maines, L. W., French, K. J., Wolpert, E. B., Antonetti, D. A., and Smith, C. D. (2006) Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases Invest. Ophthalmol. Visual Sci. 47, 5022-5031
52. Maines, L. W., Fitzpatrick, L. R., Green, C. L., Zhuang, Y., and Smith, C. D. (2010) Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease Inflammopharmacology 18, 73-85
53. Fitzpatrick, L. R., Green, C., Frauenhoffer, E. E., French, K. J., Zhuang, Y., Maines, L. W., Upson, J. J., Paul, E., Donahue, H., Mosher, T. J., and Smith, C. D. (2011) Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase Inflammopharmacology 19, 75-87
54. Maines, L. W., Fitzpatrick, L. R., French, K. J., Zhuang, Y., Xia, Z., Keller, S. N., Upson, J. J., and Smith, C. D. (2008) Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase Dig. Dis. Sci. 53, 997-1012
55. French, K. J., Zhuang, Y., Maines, L. W., Gao, P., Wang, W., Beljanski, V., Upson, J. J., Green, C. L., Keller, S. N., and Smith, C. D. (2010) Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2 J. Pharmacol. Exp. Ther. 333, 129-139
56. Gao, P., Peterson, Y. K., Smith, R. A., and Smith, C. D. (2012) Characterization of isoenzyme-selective inhibitors of human sphingosine kinases PLoS One 7, e44543
57. Beljanski, V., Lewis, C. S., and Smith, C. D. (2011) Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts Cancer Biol. Ther. 11, 524-534
58. Beljanski, V., Knaak, C., and Smith, C. D. (2010) A novel sphingosine kinase inhibitor induces autophagy in tumor cells J. Pharmacol. Exp. Ther. 333, 454-464
59. Antoon, J. W., White, M. D., Meacham, W. D., Slaughter, E. M., Muir, S. E., Elliott, S., Rhodes, L. V., Ashe, H. B., Wiese, T. E., Smith, C. D., Burow, M. E., and Beckman, B. S. (2010) Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640 Endocrinology 151, 5124-5135
60. Dickson, M. A., Carvajal, R. D., Merrill, A. H., Jr., Gonen, M., Cane, L. M., and Schwartz, G. K. (2011) A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors Clin. Cancer Res. 17, 2484-2492
61. Xiang, Y. B., Hirth, B., Kane, J. L., Liao, J. K., Noson, K. D., Yee, C., Asmussen, G., Fitzgerald, M., Klaus, C., and Booker, M. (2010) Discovery of novel sphingosine kinase-1 inhibitors. Part 2 Bioorg. Med. Chem. Lett. 20, 4550-4554
62. Xiang, Y., Asmussen, G., Booker, M., Hirth, B., Kane, J. L., Jr., Liao, J., Noson, K. D., and Yee, C. (2009) Discovery of novel sphingosine kinase 1 inhibitors Bioorg. Med. Chem. Lett. 19, 6119-6121
63. Xiang, Y., Hirth, B., Kane, J. L., Liao, J., Noson, K., and Yee, C. (2010) Patent WO/2010/033701.
64. Gustin, D. J., Li, Y., Brown, M. L., Min, X., Schmitt, M. J., Wanska, M., Wang, X., Connors, R., Johnstone, S., Cardozo, M., Cheng, A. C., Jeffries, S., Franks, B., Li, S., Shen, S., Wong, M., Wesche, H., Xu, G., Carlson, T. J., Plant, M., Morgenstern, K., Rex, K., Schmitt, J., Coxon, A., Walker, N., Kayser, F., and Wang, Z. (2013) Structure guided design of a series of sphingosine kinase (SphK) inhibitors Bioorg. Med. Chem. Lett. 23, 4608-4616
65. Rex, K., Jeffries, S., Brown, M. L., Carlson, T., Coxon, A., Fajardo, F., Frank, B., Gustin, D., Kamb, A., Kassner, P. D., Li, S., Li, Y., Morgenstern, K., Plant, M., Quon, K., Ruefli-Brasse, A., Schmidt, J., Swearingen, E., Walker, N., Wang, Z., Watson, J. E., Wickramasinghe, D., Wong, M., Xu, G., and Wesche, H. (2013) Sphingosine kinase activity is not required for tumor cell viability PLoS One 8, e68328
66. Schnute, M. E., McReynolds, M. D., Kasten, T., Yates, M., Jerome, G., Rains, J. W., Hall, T., Chrencik, J., Kraus, M., Cronin, C. N., Saabye, M., Highkin, M. K., Broadus, R., Ogawa, S., Cukyne, K., Zawadzke, L. E., Peterkin, V., Iyanar, K., Scholten, J. A., Wendling, J., Fujiwara, H., Nemirovskiy, O., Wittwer, A. J., and Nagiec, M. M. (2012) Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1 Biochem. J. 444, 79-88
67. Lynch, K. R. (2012) Building a better sphingosine kinase-1 inhibitor Biochem. J. 444, e1-2
68. Liu, K., Guo, T. L., Hait, N. C., Allegood, J., Parikh, H. I., Xu, W., Kellogg, G. E., Grant, S., Spiegel, S., and Zhang, S. (2013) Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent PLoS One 8, e56471
69. Kennedy, A. J., Mathews, T. P., Kharel, Y., Field, S. D., Moyer, M. L., East, J. E., Houck, J. D., Lynch, K. R., and Macdonald, T. L. (2011) Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells J. Med. Chem. 54, 3524-3548
70. Kharel, Y., Raje, M., Gao, M., Gellett, A. M., Tomsig, J. L., Lynch, K. R., and Santos, W. L. (2012) Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate Biochem. J. 447, 149-157
71. Neubauer, H. A. and Pitson, S. M. (2013) Roles, regulation and inhibitors of sphingosine kinase 2 FEBS J. 280, 5317-5336